SCHEMBL4299533

SCHEMBL4299533

Cc1ccccc1NC(=O)N1CCCN(C)CC1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.60
ALDH1A1 P00352 2/20 0.60
HSD17B10 Q99714 2/20 0.60
TDP1 Q9NUW8 1/20 0.60
KMT2A Q03164 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.59
GAA P10253 1/20 0.56
LMNA P02545 1/20 0.54
MEN1 O00255 1/20 0.53
POLB P06746 1/20 0.52
PKM P14618 1/20 0.52
MAPK1 P28482 1/20 0.52
ITGB1 P05556 1/20 0.52
ITGA4 P13612 1/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
HPGD P15428 1/20 0.51
ALOX12 P18054 1/20 0.51
CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4306314 0.94 KDM4E (0.67) KDM4EALDH1A1HSD17B10TDP1KMT2A
SCHEMBL27851276 0.86 POLB (0.69) KDM4EALDH1A1HSD17B10TDP1KMT2A
SCHEMBL4299031 0.86 KDM4E (0.60) KDM4EALDH1A1HSD17B10TDP1KMT2A
SCHEMBL14372224 0.82 NPC1 (0.65) KDM4EALDH1A1HSD17B10TDP1KMT2A
SCHEMBL13705808 0.81 KMT2A (0.64) KDM4EALDH1A1HSD17B10TDP1KMT2A
SCHEMBL22218698 0.79 KMT2A (0.59) KDM4EALDH1A1HSD17B10TDP1KMT2A
SCHEMBL15652116 0.79 KDM4E (0.53) KDM4EALDH1A1HSD17B10TDP1SMN1; SMN2
SCHEMBL4299291 0.79 KDM4E (0.67) KDM4EALDH1A1HSD17B10TDP1KMT2A
SCHEMBL29609509 0.78 RAB9A (0.69) KDM4EALDH1A1HSD17B10KMT2ASMN1; SMN2
SCHEMBL22218315 0.78 KDM4E (0.65) KDM4EALDH1A1HSD17B10TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118303-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2009-05-07 US disclosed
US-7485646-B2 Serotonin 5-HT3 receptor agonist RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2009-02-03 US disclosed
US-20070265277-A1 Serotonin 5-Ht3 Receptor Agonist RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2007-11-15 US disclosed
EP-1798227-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST Research Foundation Itsuu Laboratory (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118303-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST HTR3A, HTR7, HTR1A KDM4E 3740/4885ALDH1A1 2805/4885HSD17B10 2372/4885
US-20070265277-A1 Serotonin 5-Ht3 Receptor Agonist HTR3A, HTR7, HTR1A KDM4E 3740/4885ALDH1A1 2805/4885HSD17B10 2372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.